The effects of steroid hormones in HIV-related neurotoxicity: A mini review

Biological Psychiatry

Volumn 48, Issue 9, 2000, Pages 881-893

  Brooke, Sheila M ^a   Sapolsky, Robert M ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

AIDS related dementia (ADC); Estrogen; Glucocorticoids; gp120; HIV; Review

Indexed keywords

CORTICOSTEROID RECEPTOR; ESTROGEN; GLUCOCORTICOID; GLUCOSE TRANSPORTER; GLYCOPROTEIN GP 120; HYDROCORTISONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NIMODIPINE; NITRIC OXIDE SYNTHASE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN RADICAL; PREDNISONE;

AIDS RELATED COMPLEX; CALCIUM MOBILIZATION; CENTRAL NERVOUS SYSTEM; DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEUROPATHOLOGY; NEUROTOXICITY; PRIORITY JOURNAL; REVIEW;

AIDS DEMENTIA COMPLEX; ESTROGENS; GLUCOCORTICOIDS; HIV ENVELOPE PROTEIN GP120; HUMANS; STEROIDS;

EID: 0034333185     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)00922-7     Document Type: Review

References (178)

1. Rate and severity of HIV-associated dementia (HAD); Correlations with Gp41 and iNOS
2. Immunologic NO synthase; Elevation in severe AIDS dementia and induction by HIV-1 gp41
3. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage
4. The HIV-1 envelope protein gp120 induces neuronal apoptosis in hippocampal slices
5. Expression and detection of macrophage-tropic HIV-1 gp120 in the brain using conformation-dependent antibodies
6. HIV-1 gp120 increases the permeability of rat brain endothelium cultures by a mechanism involving substance P
7. SCID mice with HIV encephalitis develop behavioral abnormalities
8. Temporal trends in the incidence of HIV-1-related neurologic diseases; Multicenter AIDS Cohort Study, 1985-1992
9. Intracerebral injection of human immunodeficiency virus type 1 coat protein gp120 differentially affects the expression of nerve growth factor and nitric oxide synthase in the hippocampus of rat
10. The human immunodeficiency virus type 1 (HIV-1) glycoprotein gp120 reduces the expression of neuronal nitric oxide synthase in the hippocampus but not in the cerebral cortex and medial septal nucleus of rat
11. The HIV-1 gp120 causes ultrastructural changes typical of apoptosis in the rat cerebral cortex
12. gp120, a human immunodeficiency virus-1 coat protein, augments excitotoxic hippocampal injury in perinatal rats
13. Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8
14. Neuroprotection against oxidative stress by estrogens; Structure-activity relationship
15. The neuropathology of adult HIV infection
16. Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes; implications for AIDS dementia complex
17. Human immunodeficiency virus protein gp120 interferes with beta-adrenergic receptor-mediated protein phosphorylation in cultured rat cortical astrocytes
18. Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro
19. Preventive actions of a synthetic antioxidant in a novel animal model of AIDS dementia
20. The implication of the chemokine receptor CXCR4 in HIV-1 envelope protein-induced apoptosis is independent of the G protein-mediated signalling
21. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group
22. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide
23. Glucocorticoids synergize with tumor necrosis factor alpha in the induction of HIV expression from a chronically infected promonocytic cell line
24. Endocrine modulation of the neurotoxicity of gp120; implications for AIDS-related dementia complex
25. Energy dependency of glucocorticoid exacerbation of gp120 neurotoxicity
26. Neuropathology of human immunodeficiency virus infection
27. Lack of developmental neurotoxicity of MN rgp 120/HIV-1 administered subcutaneously to neonatal rats
28. Effect of glucocorticoids on hexose transport in rat adipocytes. Evidence for decreased transporters in the plasma membrane
29. Unique HIV type 1 V3 region sequences derived from six different regions of brain; Region-specific evolution within host-determined quasispecies
30. Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein
31. Excitotoxic cell death
32. Trophic effects of estradiol on fetal rat hypothalamic neurons
33. 2+](i) increases in a glial cell subpopulation
34. Clinical manifestations and predictors of survival in older women infected with HIV
35. 2+](i) responses not only in type-2 but also type-1 astrocytes and oligodendrocytes of the rat cerebellum
36. Transduction signals induced in rat brain cortex astrocytes by the HIV-1 gp120 glycoprotein
37. Endocrine function in the HIV wasting syndrome
38. The HIV envelope protein gp120 in the nervous system; Interactions with nitric oxide, interleukin-1beta and nerve growth factor signalling, with pathological implications in vivo and in vitro
39. Requirement for membrane lipid peroxidation in HIV-1 gp120-induced neuroblastoma cell death
40. HIV and the cortisol connection; A feasible concept of the process of AIDS
41. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures
42. Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity-dependent neurotrophic factor
43. Neuroprotective properties of calretinin against the HIV-1 gp120 toxicity
44. Tetrodotoxin blocks HIV coat protein (gp120) toxicity in primary neuronal cultures
45. Calbindin D28K-containing neurons, and not HSP70-expressing neurons, are more resistant to HIV-1 envelope (gp120) toxicity in cortical cell cultures
46. Local cerebral glucose utilization in brains of lean and genetically obese (fa/fa) rats
47. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists
48. The coat protein gp120 of HIV-1 inhibits astrocyte uptake of excitatory amino acids via macrophage arachidonic acid
49. Corticosterone exacerbates kainate-induced alterations in hippocampal tau immunoreactivity and spectrin proteolysis in vivo
50. Inflammatory cytokines and HIV-1-associated neurodegeneration; Oncostatin-M produced by mononuclear cells from HIV-1-infected individuals induces apoptosis of primary neurons
51. HIV-1-induced neuronal injury in the developing brain
52. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center
53. Differentiation of fetal mouse hypothalamic cells in serum-free medium
54. Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type
55. Antioxidants and dipyridamole inhibit HIV-1 gp120-induced free radical-based oxidative damage to human monocytoid cells
56. Adrenalectomy or metyrapone-pretreatment abolishes cerebral metabolic responses to the serotonin agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) in the hippocampus
57. Glucocorticoids and infection
58. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial
59. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins
60. The neuropathogenesis of HIV-1 infection
61. Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia
62. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions; implications for the neuropathogenesis of HIV disease
63. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1
64. Human immunodeficiency virus and the brain
65. Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist
66. Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid beta-peptide toxicity
67. Idiopathic colonic inflammation in AIDS; An open trial of prednisone
68. Glucocorticoid level and neuropsychiatric symptoms in homosexual men with HIV infection
69. 17 alpha-estradiol exerts neuroprotective effects on SK-N-SH cells
70. Estradiol protects against beta-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells
71. Pathogenesis of lentivirus infections
72. Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects
73. Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4
74. Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4
75. HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates
76. In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer's type)
77. Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia
78. Glucocorticoid modulation of gp120-induced effects on calcium-dependent degenerative events in primary hippocampal and cortical cultures
79. HIV-1 envelope glycoprotein 120 regulates brain IL-1beta system and TNF-alpha mRNAs in vivo
80. Glucocorticoids interact with gp120 in causing neurotoxicity in striatal cultures
81. Corticosterone is a preferable ligand for measuring rat brain corticosteroid receptors; Competition by RU 28362 and RU 26752 for dexamethasone binding in rat hippocampal cytosol
82. Adjuvant corticoid administration within the scope of HIV disease. Indications in wasting syndrome and other diseases within the scope of AIDS
83. Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures
84. Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems
85. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis
86. 17 beta-estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine
87. Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages
88. Reduction of cerebral glucose utilization by the HIV envelope glycoprotein Gp-120
89. Treatment of human immunodeficiency virus (HIV)-associated nephropathy
90. The mapping of HIV-1 gp160 epitopes required for interleukin-1 and tumor necrosis factor alpha production in glial cells
91. The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures
92. Impairment of excitatory amino acid transport in astroglial cells infected with the human immunodeficiency virus type 1
93. Transgenic mice with cerebral expression of human immunodeficiency virus type-1 coat protein gp120 show divergent changes in short- and long-term potentiation in CA1 hippocampus
94. Protective effect of estrogens and catecholestrogens against peroxidative membrane damage in vitro
95. 2+](i) homeostasis and induce neurotoxicity in human embryonic neurons
96. Dexamethasone therapy worsens the neuropathology of human immunodeficiency virus type 1 encephalitis in SCID mice
97. HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists
98. Neuronal injury associated with HIV-1; Approaches to treatment
99. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity
100. HIV-1 envelope protein evokes intracellular calcium oscillations in rat hippocampal neurons
101. Hypothalamo-pituitary-adrenal function in human immunodeficiency virus-infected men
102. Effect of acute stress on hippocampal glutamate levels and spectrin proteolysis in young and aged rats
103. Glucocorticoids rescue CD4+ T lymphocytes from activation-induced apoptosis triggered by HIV-1; Implications for pathogenesis and therapy
104. Cutaneous alternariosis; Role of corticosteroid-induced cutaneous fragility
105. gp120 envelope glycoproteins of human immunodeficiency viruses competitively antagonize signaling by coreceptors CXCR4 and CCR5
106. Spectrum of human immunodeficiency virus-associated neocortical damage
107. Clinical review 108; The molecular and neuroanatomical basis for estrogen effects in the central nervous system
108. Estrogen actions in the central nervous system
109. Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain
110. Glucocorticoids increase the accumulation of reactive oxygen species and enhance adriamycin-induced toxicity in neuronal culture
111. Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor
112. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity
113. gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures; protective action of TGF-beta1
114. Human immunodeficiency virus type 1 (HIV-1) infection of the nervous system; A review
115. Pneumocystis carinii infection; Current treatment and prevention
116. AIDS and the brain; Is there a chemokine connection?
117. HIV coating gp 120 glycoprotein-dependent prostaglandin E2 release by human cultured astrocytoma cells is regulated by nitric oxide formation
118. Acute respiratory failure secondary to Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A potential role for systemic corticosteroids
119. Antioxidant properties of steroids
120. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease; a randomized controlled trial. Alzheimer's Disease Cooperative Study
121. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions
122. 17beta-Estradiol inhibits the voltage-dependent L-type Ca2+ currents in aortic smooth muscle cells
123. HIV-1 coat protein gp120-induced increases in levels of intrasynaptosomal calcium
124. A phase I/II trial of nimodipine for HIV-related neurologic complications
125. Glucocorticoid interactions with memory function in schizophrenia
126. Glucocorticoid-induced impairment in declarative memory performance in adult humans
127. Symptomatology and cognitive impairment associate independently with post-dexamethasone cortisol concentrations in unmedicated schizophrenic patients
128. The syndrome of acquired glucocorticoid resistance in HIV infection
129. Altered cortisol response and hippocampal atrophy in pediatric HIV disease
130. Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates; Evidence for a role of the envelope
131. Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes; Evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations
132. Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia
133. The human immunodeficiency virus-1 envelope protein gp120 binds through its V3 sequence to the glycine site of N-methyl-D-aspartate receptors mediating noradrenaline release in the hippocampus
134. An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis
135. Development of laboratory and animal model systems for HIV-1 encephalitis and its associated dementia
136. The development of animal model systems for HIV-1 encephalitis and its associated dementia
137. A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis
138. Clinical features of adrenal insufficiency in patients with acquired immunodeficiency syndrome
139. Human brain N-methyl-D-aspartate receptors regulating noradrenaline release are positively modulated by HIV-1 coat protein gp120
140. The brain in AIDS; Central nervous system HIV-1 infection and AIDS dementia complex
141. Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains
142. HIV-1 envelope gp120 alters astrocytes in human brain cultures
143. Central nervous system expression of HIV-1 Gp120 activates the hypothalamic-pituitary-adrenal axis; Evidence for involvement of NMDA receptors and nitric oxide synthase
144. HIV-1-infection in the CNS. A pathogenesis of some neurological syndromes in the light of recent investigations
145. Estrogen replacement therapy and memory in older women
146. Molecular and biological mechansims in the development of AIDS dementia complex (ADC)
147. Stress, glucocorticoids, and damage to the nervous system; The current state of confusion
148. Induction of apoptosis by calmodulin-dependent intracellular Ca2+ elevation in CD4+ cells expressing gp 160 of HIV
149. Neurotoxicity of HIV coat protein gp120, NMDA receptors, and protein kinase C; A study with rat cerebellar granule cell cultures
150. Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus
151. Mechanisms of prionSc- and HIV-1 gp120 induced neuronal cell death
152. Pathology of HIV-1 infection of the central nervous system. A review
153. HIV glycoprotein 120 enhances intercellular adhesion molecule-1 gene expression in glial cells. Involvement of Janus kinase/signal transducer and activator of transcription and protein kinase C signaling pathways
154. Estrogen protects primary cortical neurons from glutamate toxicity
155. Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy
156. Glucocorticoids exacerbate kainic acid-induced extracellular accumulation of excitatory amino acids in the rat hippocampus
157. Physiological elevations of glucocorticoids potentiate glutamate accumulation in the hippocampus
158. The envelope glycoprotein of HIV-1 alters NMDA receptor function
159. Hypothesis on the pathogenesis of vacuolar myelopathy, dementia, and peripheral neuropathy in AIDS
160. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
161. Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine
162. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice
163. A model of human immunodeficiency virus encephalitis in scid mice
164. Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide
165. Clinical features of eight cases of opportunistic fungal pneumonias
166. Cytokines and the immune response
167. HIV-1 gp120 glycoprotein affects the astrocyte control of extracellular glutamate by both inhibiting the uptake and stimulating the release of the amino acid
168. Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes; Implications for glucocorticoid neurotoxicity
169. Neuropathogenesis of HIV-1 infection. Outstanding questions
170. Tat, a human immunodeficiency virus-1-derived protein, augments excitotoxic hippocampal injury in neonatal rats
171. Clinical response to prolonged corticosteroids in a patient with human immunodeficiency virus-associated nephropathy
172. Measurement of CNS HIV burden and its association with neurologic damage
173. Glucocorticoid medication, memory and steroid psychosis in medical illness
174. Cognitive effects of corticosteroids
175. Dysregulation of signal transduction pathways as a potential mechanism of nervous system alterations in HIV-1 gp120 transgenic mice and humans with HIV-1 encephalitis
176. Inhibition of HIV-1 gp120-induced apoptosis in neuroblastoma SK-N-SH cells by an antisense oligodeoxynucleotide against p53